Skip to search.
 STI Down 0.20%

Biogen Inc. (BIIB)

-NasdaqGS
290.16 Up 7.37(2.61%) 03:53 SGT - Nasdaq Real Time Price
Prev Close:282.79
Open:285.00
Bid:289.79 x 200
Ask:289.87 x 700
1y Target Est:345.50
Beta:0.3261
Earnings Date:22 Jul - 26 Jul (Est.)
Day's Range:284.95 - 291.63
52wk Range:242.07 - 420.99
Volume:1,668,590
Avg Vol (3m):1,619,730
Market Cap:63.56B
P/E (ttm):17.83
EPS (ttm):16.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 2.61%63.56B
PFEUp 0.23%210.39B
ABTUp 0.74%58.16B

Key Statistics

Forward P/E (1 yr):14.45
P/S (ttm):5.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :18.85
Quarterly EPS Est (Jun-16) :4.68
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback